The latest immunotherapy news and developments
AACR 2024: Immunotherapy combination before surgery improves pancreatic cancer outcomes
A pilot study led by UCLA Health Jonsson Comprehensive Cancer Center (USA) investigators suggests that…
Browsing: Immunotherapy
AACR 2024: Novel ADC and immunotherapy combo shows promise in endometrial cancer subtype
In a small, investigator-initiated phase 2 study by Dana-Farber Cancer Institute investigators (USA), a novel…
AACR 2024: Novel immunotherapies show promise for patients with kidney cancer and for solid organ transplant recipients with skin cancer
Researchers from The University of Texas MD Anderson Cancer Center, USA, presented encouraging findings today from…
Genetically engineered dendritic cells enhance the power of immunotherapy against lung cancer
A study by researchers at the UCLA Health Jonsson Comprehensive Cancer Center suggests that injecting engineered dendritic…
Biocompatible nanoparticles to enhance systemic delivery of cancer immunotherapy
Researchers are developing and validating patent-pending poly (lactic-co-glycolic acid), or PLGA, nanoparticles modified with adenosine…
Enhanced melanoma vaccine offers improved survival for men
A second-generation melanoma vaccine being developed at UVA Cancer Center, USA, improves long-term survival for…
Genetic test identifies patients with triple negative breast cancer who are unlikely to respond to immunotherapies
Researchers have developed a genetic test that can identify how patients with triple negative early-stage…
Mapping the evolution of urinary tract cancer cells
Researchers at Weill Cornell Medicine have performed the most comprehensive analysis to date of cancer…
Immunotherapy targeting cancer fusion protein may hold key to treating rare liver cancer
Fibrolamellar carcinoma (FLC) is a rare liver cancer with a poor prognosis if not addressed…
AACR Preview
Investigators from the UCLA Health Jonsson Comprehensive Cancer Center will discuss the latest breakthroughs and cutting-edge science…